Dr. Stephen Sobel, M.D

NPI: 1356440440
Total Payments
$73,157
2023 Payments
$17,364
Companies
9
Transactions
106

Payment Breakdown by Category

Other$69,734 (95.3%)
Travel$2,018 (2.8%)
Food & Beverage$1,262 (1.7%)
Education$143.14 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $69,734 51 95.3%
Travel and Lodging $2,018 24 2.8%
Food and Beverage $1,262 25 1.7%
Education $143.14 6 0.2%

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $23,110 25 $0 (2023)
Takeda Pharmaceuticals America, Inc. $22,962 29 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $16,100 22 $0 (2019)
Allergan, Inc. $10,351 21 $0 (2020)
Otsuka America Pharmaceutical, Inc. $221.43 3 $0 (2017)
Ironshore Pharmaceuticals Inc. $179.64 3 $0 (2019)
Sunovion Pharmaceuticals Inc. $125.00 1 $0 (2018)
Axsome Therapeutics, Inc. $94.14 1 $0 (2023)
Supernus Pharmaceuticals, Inc. $13.26 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2023 $17,364 19 AbbVie Inc. ($17,270)
2022 $2,458 3 ABBVIE INC. ($2,458)
2021 $3,395 5 AbbVie Inc. ($3,382)
2020 $1,977 3 Allergan, Inc. ($1,977)
2019 $12,568 23 Allergan Inc. ($7,923)
2018 $12,211 21 Takeda Pharmaceuticals U.S.A., Inc. ($11,634)
2017 $23,184 32 Takeda Pharmaceuticals America, Inc. ($22,962)

All Payment Transactions

106 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
09/14/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage Cash or cash equivalent $94.14 General
Category: Psychology/Psychiatric
08/11/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: NEUROSCIENCE
08/01/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $18.34 General
Category: NEUROSCIENCE
06/08/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: NEUROSCIENCE
05/26/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.64 General
Category: NEUROSCIENCE
05/26/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $13.10 General
Category: NEUROSCIENCE
05/19/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: NEUROSCIENCE
04/27/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: NEUROSCIENCE
04/20/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: NEUROSCIENCE
04/18/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $15.72 General
Category: NEUROSCIENCE
04/06/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.83 General
Category: NEUROSCIENCE
04/06/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $22.27 General
Category: NEUROSCIENCE
03/02/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,440.00 General
Category: NEUROSCIENCE
02/16/2023 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,840.00 General
Category: NEUROSCIENCE
01/28/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $635.50 General
Category: NEUROSCIENCE
01/28/2023 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $315.81 General
Category: NEUROSCIENCE
01/28/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $47.21 General
Category: NEUROSCIENCE
01/28/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $45.70 General
Category: NEUROSCIENCE
01/28/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.52 General
Category: NEUROSCIENCE
11/10/2022 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: NEUROSCIENCE
11/10/2022 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $36.25 General
Category: NEUROSCIENCE
11/10/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.05 General
Category: NEUROSCIENCE
07/22/2021 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,920.00 General
Category: NEUROSCIENCE
07/22/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.46 General
Category: NEUROSCIENCE
07/22/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $6.16 General
Category: NEUROSCIENCE

About Dr. Stephen Sobel, M.D

Dr. Stephen Sobel, M.D is a Specialist healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356440440.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Sobel, M.D has received a total of $73,157 in payments from pharmaceutical and medical device companies, with $17,364 received in 2023. These payments were reported across 106 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($69,734).

Practice Information

  • Specialty Specialist
  • Location San Diego, CA
  • Active Since 09/22/2006
  • Last Updated 07/21/2022
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1356440440

Products in Payments

  • Trintellix (Drug) $39,063
  • VRAYLAR (Drug) $33,421
  • REXULTI (Drug) $221.43
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $179.64
  • LATUDA (Drug) $125.00
  • Auvelity (Drug) $94.14
  • VIIBRYD (Drug) $40.00
  • QELBREE (Drug) $13.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in San Diego